- Home
- XNCR vs BTX Comparison
XNCR vs BTX Comparison
Compare XNCR & BTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XNCR | BTX |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 881.9M | 780.8M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | XNCR | BTX |
|---|---|---|
| Price | $11.29 | $6.42 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $22.89 | N/A |
| AVG Volume (30 Days) | 560.6K | ★ 812.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.58% |
| EPS Growth | ★ 65.36 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.52 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $5.10 |
| 52 Week High | $18.69 | $7.50 |
Technical Indicators
Market Signals| Indicator | XNCR | BTX |
|---|---|---|
| Relative Strength Index (RSI) | 42.45 | 42.61 |
| Support Level | $11.02 | $6.18 |
| Resistance Level | $12.58 | $6.94 |
| Average True Range (ATR) | 0.89 | 0.16 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 16.33 | 19.75 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About BTX BlackRock Technology and Private Equity Term Trust
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.